Word on the Street.

"Chalk it up to lessons learned: We'll never start a trial we don't have the funds to finish again."

- Patrick Smith, CEO of Curaxis Inc. (formerly Voyager Pharmaceuticals Inc.), which had to halt Phase III testing of Alzheimer's drug Memryte in 2005 after running out of money

"Just because there are failures doesn't mean you should stop."

…